Priority,Rule
High,"ENPP3, DLL3, KRAS-G12C or Pan-RAS or Pan-KRAS or KRAS-G12D and solid tumors, EGFR degrader or PROTAC, Oncolytic virus or oHSV or adenovirus or and NSCLC, Radioenhancers or Radioligands or Radiotherapeutics or RLT and NSCLC"
Medium,"Volrustomig or MEDI5752 or MEDI-5752, Rivelgostomig or AZD-2936 or AZD2936, BNT327 or BNT-327 or PM8002, SSGJ-707, IBI-363 or IBI363, PD-1/IL-2 or IL-2/PD-1, PD-1/IL-15 or IL-15/PD-1, Mesothelin or MSLN, TAOK1, PTK7 or PTK-7, CRAF degrader, EGFR degrader, any new targets for squamous NSCLC, any new targets for SCLC  "
